Cbdmd, Inc. cash flow statement
In fiscal 2025, Cbdmd, Inc.'s operations generated −$1.5m of cash; it spent $184,172 on capital projects, leaving free cash flow of −$1.6m.
Cash flow statement
| Fiscal year | 2016Sept 2016 | 2017Sept 2017 | 2018Sept 2018 | 2019Sept 2019 | 2020Sept 2020 | 2021Sept 2021 | 2022Sept 2022 | 2023Sept 2023 | 2024Sept 2024 | 2025Sept 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | −3 | −2 | −6 | −15 | −11 | −14 | −15 | −4 | −0 | −1 | −2 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Stock-based pay | 0 | 0 | 1 | 2 | 2 | 1 | — | — | — | — | — |
| Capital spending | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
| Free cash flow | −3 | −2 | −6 | −17 | −12 | −14 | −16 | −5 | −1 | −2 | −2 |
| Free cash flow after stock pay | −3 | −2 | −6 | −19 | −14 | −16 | — | — | — | — | — |
| Dividends paid | — | — | — | 0 | 0 | 3 | — | — | — | — | — |
| Shares issued | 2 | 1 | 11 | 19 | 17 | 0 | 0 | 2 | 0 | 0 | — |
| Quarter | 2024 Q4Sept 2024 | 2025 Q1Dec 2024 | 2025 Q2Mar 2025 | 2025 Q3Jun 2025 | 2025 Q4Sept 2025 | 2026 Q1Dec 2025 | 2026 Q2Mar 2026 | 2026 Q3Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 167 | −318 | −189 | −704 | −241 | −812 | −723 | −442 |
| Depreciation and amortisation | 109 | 107 | 95 | 89 | 71 | 54 | 45 | 44 |
| Capital spending | 10 | 164 | 16 | 1 | 3 | 165 | 6 | 18 |
| Free cash flow | 157 | −482 | −205 | −706 | −244 | −977 | −728 | −460 |
| Shares issued | 0 | — | — | 0 | 0 | — | — | — |
Compare with peers
- Axil Brands, Inc. cash flow
- Natural Health Trends Corp cash flow
- Fitlife Brands, Inc. cash flow
- United Guardian Inc cash flow
- Mannatech Inc cash flow
Head to head: AXIL vs YCBDNHTC vs YCBDFTLF vs YCBDUG vs YCBD
More: Personal Care Products stocks compared, Consumer Staples sector, rankings of US companies